one thought on “chess grandmasters show the same longevity advantage as elite athletes”
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
. fueled by low vaccination rates led to 9,000 sick children and 10 infant deaths.
.
a sign at a planned parenthood clinic is pictured in oklahoma city, in 2015.
.